SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-100291
Filing Date
2021-08-04
Accepted
2021-08-04 21:08:16
Documents
1
Period of Report
2021-08-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2123911-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2123911-8_4seq1.xml 4 3627
  Complete submission text file 0001104659-21-100291.txt   5121
Mailing Address C/O OPTIMER PHARMACEUTICALS, INC 101 HUDSON STREET SAN DIEGO CA 07302
Business Address
Webster Stephen W (Reporting) CIK: 0001438421 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 211145926

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations